Association of early PSA decline and time to PSA progression in abiraterone acetate-treated metastatic castration-resistant prostate cancer; a post-hoc analysis of Japanese phase 2 trials-Reference-Cited by-同舟云学术

Association of early PSA decline and time to PSA progression in abiraterone acetate-treated metastatic castration-resistant prostate cancer; a post-hoc analysis of Japanese phase 2 trials

Published:2016-06-08 Issue:1 Volume:16 Page:
ISSN:1471-2490
Container-title:BMC Urology
language:en
Short-container-title:BMC Urol

Author:

Nakayama Masahiko,Kobayashi Hisanori,Takahara Tomihiro,Oyama Ryo,Imanaka Keiichiro,Yoshizawa Kazutake

Funder

Janssen Pharmaceuticals

Publisher

Springer Science and Business Media LLC

Subject

Urology,Reproductive Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12894-016-0148-4.pdf

Reference22 articles.

1. Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, Wolfe C, et al. The global burden of cancer 2013. JAMA Oncol. 2015;1(4):505–27.

2. Huggins C, Masina MH, Eichelberger L, Wharton JD. Quantitative studies of prostatic secretion : I. Characteristics of the normal secretion; the influence of thyroid, suprarenal, and tstis extirpation and androgen substitution on the prostatic output. J Exp Med. 1939;70(6):543–56.

3. Barrie SE, Potter GA, Goddard PM, Haynes BP, Dowsett M, Jarman M. Pharmacology of novel steroidal inhibitors of cytochrome P450(17) alpha (17 alpha-hydroxylase/C17-20 lyase). J Steroid Biochem Mol Biol. 1994;50(5–6):267–73.

4. de Bono JS, Logothetis CJ, Molina A, Fizazi K, North S, Chu L, Chi KN, Jones RJ, Goodman OB, Jr., Saad F, et al. Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med. 2011;364(21):1995–2005.

5. Ryan CJ, Smith MR, de Bono JS, Molina A, Logothetis CJ, de Souza P, Fizazi K, Mainwaring P, Piulats JM, Ng S, et al. Abiraterone in metastatic prostate cancer without previous chemotherapy. N Engl J Med. 2013;368(2):138–48.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Early PSA Response After Abiraterone Treatment for Metastatic Castration Resistant Prostate Cancer;2024-06-12

2. Prostate-Specific Antigen Kinetics Effects on Outcomes of Low-Volume Metastatic Prostate Cancer Patients Receiving Androgen Deprivation Therapy;Journal of Oncology;2021-08-26

3. Treatment and trials in non-metastatic castration-resistant prostate cancer;Nature Reviews Urology;2021-05-17

4. Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration‐resistant prostate cancer patients during abiraterone/enzalutamide treatment;The Prostate;2021-04-27

5. Levels of plasma glycan-binding auto-IgG biomarkers improve the accuracy of prostate cancer diagnosis;Molecular and Cellular Biochemistry;2020-08-20